Evidence map›Paper›PMID 23512608›Full record

ReviewCurrent atherosclerosis reports2013

Polyphenols, inflammation, and cardiovascular disease.

Christy C Tangney, Heather E Rasmussen

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Current atherosclerosis reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03584581 (Effects on Lipid Metabolism of Olive Extracts Rich in Polyphenols), which is not on this map. Cited by 134 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
134citing papers in PubMed, 3 pooled it
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03584581 phase2unknown statusnot on this mapstarted 2018, after this paper: background citation

Effects on Lipid Metabolism of Olive Extracts Rich in Polyphenols

TypeinterventionalSponsorUniversidad Miguel Hernandez de ElcheRan2018 to 2018Enrolled60ConditionsCholesterol, Metabolic Disorder, Metabolic SyndromeArmsOlive polyphenols, Control
3 · Its place in the literature

Who cites it

134 citing papers in PubMed, 3 syntheses or guidelines pooled it, 333 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Impact of Obesity-Induced Inflammation on Cardiovascular Diseases (CVD).International journal of molecular sciences · 2021
    Pooled it
  4. Trial
  5. Feasibility of lifestyle interventions for cognition in adults with low education.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Associations of Coffee Drinking with Systemic Immune and Inflammatory Markers.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2015
    Trial
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

74 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Christy C TangneyRush University Medical Center, 1700 W Van Buren, Ste 425, Chicago, IL 60612, USA. ctangney@rush.edu
Heather E Rasmussen
Rush University · USRush University Medical Center · US

Funding

Epidemiologic Study of Brain Vitamin E, Diet & Age-Related Neurologic DiseasesR01AG031553 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI MORRIS, MARTHA CLARE · 2008 to 2012
$3.7M
NIA NIH HHS R01 AG031553
6 · The paper itself

Abstract

Polyphenols are compounds found in foods such as tea, coffee, cocoa, olive oil, and red wine and have been studied to determine if their intake may modify cardiovascular disease (CVD) risk. Historically, biologic actions of polyphenols have been attributed to antioxidant activities, but recent evidence suggests that immunomodulatory and vasodilatory properties of polyphenols may also contribute to CVD risk reduction. These properties will be discussed, and recent epidemiological evidence and intervention trials will be reviewed. Further identification of polyphenols in foods and accurate assessment of exposures through measurement of biomarkers (i.e., polyphenol metabolites) could provide the needed impetus to examine the impact of polyphenol-rich foods on CVD intermediate outcomes (especially those signifying chronic inflammation) and hard endpoints among high risk patients. Although we have mechanistic insight into how polyphenols may function in CVD risk reduction, further research is needed before definitive recommendations for consumption can be made.

Indexed as

AntioxidantsCardiovascular DiseasesFlavonoidsFoodHumansImmunomodulationLignansPhenolsPolyphenolsRisk FactorsStilbenesVasodilationAntioxidantsFlavonoidsLignansPhenolsPolyphenolsStilbenes

Identifiers

PMID23512608
PMCPMC3651847
OpenAlexW2031814313

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.